tiprankstipranks
Trending News
More News >
Hikma Pharmaceuticals PLC (HKMPY)
OTHER OTC:HKMPY
US Market
Advertisement

Hikma Pharmaceuticals (HKMPY) Ratios

Compare
43 Followers

Hikma Pharmaceuticals Ratios

HKMPY's free cash flow for Q2 2025 was $―. For the 2025 fiscal year, HKMPY's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.24 1.57 1.86 2.06 1.87
Quick Ratio
0.72 0.90 1.14 1.38 1.13
Cash Ratio
0.11 0.15 0.25 0.42 0.31
Solvency Ratio
0.15 0.15 0.16 0.31 0.28
Operating Cash Flow Ratio
0.26 0.45 0.49 0.63 0.45
Short-Term Operating Cash Flow Coverage
0.75 4.05 3.81 5.70 2.94
Net Current Asset Value
$ -446.00M$ -371.00M$ -324.00M$ 189.00M$ -65.00M
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.25 0.29 0.19 0.23
Debt-to-Equity Ratio
0.62 0.54 0.60 0.34 0.44
Debt-to-Capital Ratio
0.38 0.35 0.38 0.26 0.30
Long-Term Debt-to-Capital Ratio
0.24 0.31 0.33 0.21 0.24
Financial Leverage Ratio
2.23 2.13 2.09 1.78 1.94
Debt Service Coverage Ratio
0.61 1.98 2.09 3.55 2.73
Interest Coverage Ratio
13.00 4.22 6.58 8.43 8.39
Debt to Market Cap
0.28 0.45 0.59 0.22 0.21
Interest Debt Per Share
7.12 11.57 12.14 7.92 8.48
Net Debt to EBITDA
2.40 1.76 2.05 0.55 0.82
Profitability Margins
Gross Profit Margin
42.72%48.94%49.19%50.96%51.30%
EBIT Margin
14.46%12.80%12.04%23.46%26.14%
EBITDA Margin
17.01%19.44%19.59%30.00%31.91%
Operating Profit Margin
16.17%12.77%20.14%22.80%24.73%
Pretax Profit Margin
14.37%9.77%9.26%21.31%23.84%
Net Profit Margin
11.54%6.61%7.47%16.49%18.41%
Continuous Operations Profit Margin
11.60%6.68%7.59%16.41%18.37%
Net Income Per EBT
80.30%67.62%80.69%77.39%77.24%
EBT Per EBIT
88.85%76.57%45.96%93.47%96.37%
Return on Assets (ROA)
6.68%4.06%4.20%9.63%10.42%
Return on Equity (ROE)
15.44%8.64%8.81%17.16%20.19%
Return on Capital Employed (ROCE)
14.87%10.98%14.94%17.34%18.64%
Return on Invested Capital (ROIC)
9.96%7.16%11.73%12.92%13.62%
Return on Tangible Assets
8.55%5.31%5.62%12.10%13.22%
Earnings Yield
6.88%7.58%9.09%12.10%10.66%
Efficiency Ratios
Receivables Turnover
3.01 3.64 3.24 3.27 3.54
Payables Turnover
3.01 4.75 4.40 4.78 4.09
Inventory Turnover
1.70 1.65 1.65 1.80 1.51
Fixed Asset Turnover
2.34 2.52 2.33 2.23 2.19
Asset Turnover
0.58 0.61 0.56 0.58 0.57
Working Capital Turnover Ratio
8.18 3.42 2.52 2.59 3.68
Cash Conversion Cycle
214.66 244.88 251.08 237.89 256.26
Days of Sales Outstanding
121.33 100.17 112.68 111.66 103.22
Days of Inventory Outstanding
214.40 221.54 221.45 202.62 242.37
Days of Payables Outstanding
121.07 76.83 83.05 76.38 89.33
Operating Cycle
335.73 321.70 334.13 314.27 345.59
Cash Flow Ratios
Operating Cash Flow Per Share
2.36 5.51 4.73 5.52 3.93
Free Cash Flow Per Share
1.63 3.66 2.72 3.54 2.03
CapEx Per Share
0.74 1.85 2.01 1.98 1.90
Free Cash Flow to Operating Cash Flow
0.69 0.66 0.58 0.64 0.52
Dividend Paid and CapEx Coverage Ratio
1.55 1.78 1.51 1.83 1.39
Capital Expenditure Coverage Ratio
3.21 2.98 2.36 2.79 2.07
Operating Cash Flow Coverage Ratio
0.34 0.51 0.41 0.75 0.50
Operating Cash Flow to Sales Ratio
0.16 0.21 0.21 0.25 0.20
Free Cash Flow Yield
6.80%8.06%7.37%5.88%2.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.54 13.20 11.01 8.26 9.38
Price-to-Sales (P/S) Ratio
1.66 0.87 0.82 1.36 1.73
Price-to-Book (P/B) Ratio
2.16 1.14 0.97 1.42 1.89
Price-to-Free Cash Flow (P/FCF) Ratio
14.72 6.21 6.78 8.51 16.85
Price-to-Operating Cash Flow Ratio
10.24 4.12 3.90 5.45 8.71
Price-to-Earnings Growth (PEG) Ratio
<0.01 5.54 -0.20 0.00 -1.02
Price-to-Fair Value
2.16 1.14 0.97 1.42 1.89
Enterprise Value Multiple
12.16 6.25 6.25 5.09 6.23
Enterprise Value
6.65B 6.00B 5.15B 7.38B 8.70B
EV to EBITDA
12.16 10.73 10.45 9.63 11.64
EV to Sales
2.07 2.09 2.05 2.89 3.71
EV to Free Cash Flow
18.32 14.85 16.89 18.04 36.23
EV to Operating Cash Flow
12.62 9.87 9.72 11.57 18.74
Tangible Book Value Per Share
5.98 10.04 9.14 13.64 10.78
Shareholders’ Equity Per Share
11.19 19.90 19.06 21.24 18.09
Tax and Other Ratios
Effective Tax Rate
0.19 0.32 0.18 0.23 0.23
Revenue Per Share
14.42 26.03 22.47 22.10 19.84
Net Income Per Share
1.66 1.72 1.68 3.65 3.65
Tax Burden
0.80 0.68 0.81 0.77 0.77
Interest Burden
0.99 0.76 0.77 0.91 0.91
Research & Development to Revenue
0.05 0.05 0.06 0.06 0.06
SG&A to Revenue
0.00 0.22 0.20 0.19 0.20
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.01 0.01
Income Quality
3.96 2.16 2.27 1.17 0.83
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis